Citrate transporter inhibitors: possible new anticancer agents

Area of Science:

• Oncology and Cancer Metabolism

Background:

• Aberrant cellular metabolism is a hallmark of cancer, contributing significantly to tumor pathogenesis.
• Citrate, a key intermediary metabolite, is often over-available in cancer cells, promoting rapid growth and proliferation.
• Citrate transporters play a crucial role in regulating intracellular citrate levels.

Purpose of the Study:

• To review and summarize the anticancer potential of various citrate transporter inhibitors.
• To explore the therapeutic strategies involving inhibition of plasma membrane and mitochondrial citrate transporters.

Main Methods:

• Literature review of studies investigating citrate transporter inhibitors for anticancer activity.
• Analysis of different classes of inhibitors and their mechanisms of action.
• Examination of combination therapies involving citrate transporter inhibitors.

Main Results:

• Citrate transporter inhibition demonstrates significant anticancer effects.
• Targeting citrate transporters, individually or in combination, can impede cancer cell growth and proliferation.
• Synergistic effects observed when combined with other metabolic inhibitors.

Conclusions:

• Inhibiting citrate transporters represents a viable and consequential chemotherapeutic strategy.
• Targeting cancer cell metabolism via citrate transporters offers a novel approach to cancer treatment.
• Further research into citrate transporter inhibitors holds promise for future cancer therapies.